Literature DB >> 16019961

Co-morbidity of smoking in patients with psychiatric and substance use disorders.

David Kalman1, Sandra Baker Morissette, Tony P George.   

Abstract

This article reviews cigarette smoking in patients with psychiatric disorders (PD) and substance use disorders (SUD). Rates of smoking are approximately 23% in the U.S. population but approximately two- to four-fold higher in patients with PD and SUD. Many remaining smokers have had repeated smoking cessation failures, possibly due to the presence of co-morbid PD and SUDs. There is modest, evidence-based support for effective treatment interventions for nicotine addiction in PD and SUD. Further research is needed to increase our understanding of nicotine addiction in PD and SUD and develop more effective treatment interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019961      PMCID: PMC1199553          DOI: 10.1080/10550490590924728

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  154 in total

1.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

2.  Smoking and drinking among alcoholics in treatment: cross-sectional and longitudinal relationships.

Authors:  S B Gulliver; D Kalman; D J Rohsenow; S M Colby; C A Eaton; P M Monti
Journal:  J Stud Alcohol       Date:  2000-01

3.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol.

Authors:  Ola Blomqvist; Carlos A Hernandez-Avila; Jeffrey Van Kirk; Jed E Rose; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2002-03       Impact factor: 3.455

5.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Development of major depression after treatment for smoking cessation.

Authors:  J Y Tsoh; G L Humfleet; R F Muñoz; V I Reus; D T Hartz; S M Hall
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

7.  Smoking behaviors across anxiety disorders.

Authors:  Randi E McCabe; Susan M Chudzik; Martin M Antony; Lisa Young; Richard P Swinson; Michael J Zolvensky
Journal:  J Anxiety Disord       Date:  2004

Review 8.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

Review 9.  Group treatment for smoking cessation among persons with schizophrenia.

Authors:  J Addington
Journal:  Psychiatr Serv       Date:  1998-07       Impact factor: 3.084

10.  Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.

Authors:  J M Schmitz; H Rhoades; J Grabowski
Journal:  Addict Behav       Date:  1995 Mar-Apr       Impact factor: 3.913

View more
  204 in total

1.  Smoking cessation quitlines: an underrecognized intervention success story.

Authors:  Edward Lichtenstein; Shu-Hong Zhu; Gary J Tedeschi
Journal:  Am Psychol       Date:  2010 May-Jun

2.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

3.  Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder.

Authors:  Timothy P Carmody; Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Anne M Joseph; Jean C Beckham; Jessica W Cook
Journal:  Nicotine Tob Res       Date:  2012-01-23       Impact factor: 4.244

4.  Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008.

Authors:  Jason Q Purnell; Luke J Peppone; Kassandra Alcaraz; Amy McQueen; Joseph J Guido; Jennifer K Carroll; Enbal Shacham; Gary R Morrow
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

Review 5.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

6.  How is tobacco treatment provided during drug treatment?

Authors:  Jamie J Hunt; A Paula Cupertino; Susan Garrett; Peter D Friedmann; Kimber P Richter
Journal:  J Subst Abuse Treat       Date:  2011-08-09

7.  Structural and behavioral correlates of abnormal encoding of money value in the sensorimotor striatum in cocaine addiction.

Authors:  Anna B Konova; Scott J Moeller; Dardo Tomasi; Muhammad A Parvaz; Nelly Alia-Klein; Nora D Volkow; Rita Z Goldstein
Journal:  Eur J Neurosci       Date:  2012-07-09       Impact factor: 3.386

8.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

9.  Differences in White Matter Microstructure and Connectivity in Nontreatment-Seeking Individuals with Alcohol Use Disorder.

Authors:  Evgeny J Chumin; Joaquín Goñi; Meredith E Halcomb; Timothy C Durazzo; Mario Dzemidzic; Karmen K Yoder
Journal:  Alcohol Clin Exp Res       Date:  2018-04-14       Impact factor: 3.455

10.  Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

Authors:  Rosemarie A Martin; Damaris J Rohsenow; Jennifer W Tidey
Journal:  J Subst Abuse Treat       Date:  2019-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.